Osteopontin: A Potential Biomarker for Successful Bee Venom Immunotherapy and a Potential Molecule for Inhibiting IgE-mediated Allergic Responses
Venom immunotherapy (VIT) is proven to be curative for insect allergy, but the mechanisms and the biomarkers associated with clinical efficacy remain elusive. We report herein the discovery of a leading candidate biomarker, osteopontin (OPN), for VIT. From cDNA microarray and clustering analyses, an...
Main Authors: | Satoshi Konno, Nobuyuki Hizawa, Masaharu Nishimura, Shau-Ku Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015309898 |
Similar Items
-
Venom Immunotherapy: From Proteins to Product to Patient Protection
by: Martin Feindor, et al.
Published: (2021-09-01) -
Biological Effects of Osteopontin on Endothelial Progenitor Cells
by: Altalhi, Wafa
Published: (2011) -
Biological Effects of Osteopontin on Endothelial Progenitor Cells
by: Altalhi, Wafa
Published: (2011) -
Biological Effects of Osteopontin on Endothelial Progenitor Cells
by: Altalhi, Wafa
Published: (2011) -
Biological Effects of Osteopontin on Endothelial Progenitor Cells
by: Altalhi, Wafa
Published: (2011)